Abstract
The use of elective single embryo transfers (eSET) in ART was only 15% in 2012, and significantly lags behind Western European countries where eSET is the norm. The reasons for this are many, including the absence of universal coverage for ART, lack of patient education, desire for twin pregnancy, financial reasons, inadequate counseling by providers, and fear of a lower success rates compared to double embryo transfers (DET). Even in mandated states, eSET utilization is suboptimal. We have designed an innovative trial to encourage couples undergoing ART to choose eSET: patients were offered free HMG (Menopur), free freezing of all extra embryos, and free storage for one year (> $5,000 savings) if they agreed to have an eSET.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
